SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on December 5, 2018. The filing serves as a Regulation FD disclosure regarding a slide presentation intended for use at the Annual LD Micro Main Event Conference in Los Angeles on the same date. The company is incorporated in California and identifies as an emerging growth company.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of presentation materials rather than a financial statement filing.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely incorporates by reference the attached investor presentation (Exhibit 99.1).
Guidance, Outlook, and Risks
Management commentary is contained within the attached presentation materials, which speak as of December 5, 2018. The company explicitly disclaims any obligation to update these materials or reflect events occurring after the report date. The presentation was webcast live and archived for 30 days on the company's website. The information in this Item 7.01 and the attached exhibit is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference in another filing.
Key Facts for Investor Verification
- Verify the content of the investor presentation (Exhibit 99.1) attached to this filing for specific business updates.
- Confirm the webcast archive availability on the company website (www.secondsight.com) under the Investors section.
- Note that the presentation materials are not considered "filed" under Section 18 of the Exchange Act.
- Check for any subsequent filings that may incorporate these presentation materials by reference.